KM

Kuldeep Mayabhai Bhammar

Active Director Designated Partner DIN 08958966
DIN 08958966 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Kuldeep Mayabhai Bhammar

Data last updated:

Kuldeep Mayabhai Bhammar is a Designated Partner at Amreli Institute Of Medical Science Llp (since 2020). The company operates in Healthcare.

DIN 08958966
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Nov 20202020Active

Board colleagues of Kuldeep Mayabhai Bhammar

Directorship timeline

Open interactive timeline →
Amreli Institute Of Medical Science Llp
Premium access

Shareholding and investment profile for Kuldeep Mayabhai Bhammar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldeep Mayabhai Bhammar

Kuldeep Mayabhai Bhammar currently holds 1 directorship: Amreli Institute Of Medical Science Llp (Designated Partner, since 12 Nov 2020).

Kuldeep Mayabhai Bhammar was first appointed on 12 Nov 2020 as Designated Partner at Amreli Institute Of Medical Science Llp.

The current boards of Kuldeep Mayabhai Bhammar's companies include Bina Gordhanbhai Rabadia (Amreli Institute Of Medical Science Llp), Keyurbhai Kotadiya (Amreli Institute Of Medical Science Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available